1. Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY;
2. Indiana University School of Medicine and Simon Cancer Center, Richard L. Roudebush VA Medical Center, Indianapolis, IN;
3. Baylor Institute for Immunology Research, Dallas, TX;
4. Unité d’Immuno-hématologie, Assistance Publique–Hôpitaux de Paris, Centre d’Investigations Cliniques 1427, Hôpital Saint Louis Lariboisière, Paris, France;
5. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA;
6. James P. Wilmot Cancer Center, University of Rochester Strong Memorial Hospital, Rochester, NY;
7. Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
8. The Judy and Bernard Briskin Myeloma Center, City of Hope, Duarte, CA;
9. Columbia University Medical Center, New York, NY;
10. Division of Hematology-Oncology, Tufts Medical Center, Boston, MA;
11. Janssen Research & Development, Raritan, NJ; and
12. Janssen Research & Development, Spring House, PA